Π ΠΎΠ»Ρ Π°ΠΏΠΎΠ»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½Π° Π-1 ΠΈ Π°ΠΏΠΎΠ»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½Π° Π Π² ΡΠ΅Π³ΡΠ»ΡΡΠΈΠΈ Π±ΠΈΠΎΡΠΈΠ½ΡΠ΅Π·Π° Π±Π΅Π»ΠΊΠ° ΠΈ Π½ΡΠΊΠ»Π΅ΠΈΠ½ΠΎΠ²ΡΡ ΠΊΠΈΡΠ»ΠΎΡ Π² ΠΊΡΠ»ΡΡΡΡΠ΅ Π½ΠΎΡΠΌΠ°Π»ΡΠ½ΡΡ ΠΈ ΠΎΠΏΡΡ ΠΎΠ»Π΅Π²ΡΡ Π³Π΅ΠΏΠ°ΡΠΎΡΠΈΡΠΎΠ²
ΠΠΈΡΡΠ΅ΡΡΠ°ΡΠΈΡ
Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ ΡΠ°Π±ΠΎΡΡ ΡΠ²ΠΈΠ΄Π΅ΡΠ΅Π»ΡΡΡΠ²ΡΡΡ ΠΎ ΡΠΎΠΌ, ΡΡΠΎ ΠΌΠ°ΠΊΡΠΎΡΠ°Π³ΠΈ Π·Π°Π½ΠΈΠΌΠ°ΡΡ ΠΊΠ»ΡΡΠ΅Π²ΡΠ΅ ΠΏΠΎΠ·ΠΈΡΠΈΠΈ Π² ΡΠ΅Π³ΡΠ»ΡΡΠΈΠΈ ΠΏΡΠΎΡΠ΅ΡΡΠΎΠ² ΡΠ΅Π³Π΅Π½Π΅ΡΠ°ΡΠΈΠΈ ΠΈ ΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠΉ ΠΏΡΠΎΠ»ΠΈΡΠ΅ΡΠ°ΡΠΈΠΈ. ΠΡΠΈ ΠΌΠ΅ΠΆΠΊΠ»Π΅ΡΠΎΡΠ½ΡΠ΅ Π²Π·Π°ΠΈΠΌΠΎΠ΄Π΅ΠΉΡΡΠ²ΠΈΡ ΠΏΡΠΎΡΠ²Π»ΡΡΡ ΡΠ΅Π±Ρ Π½Π΅ ΡΠΎΠ»ΡΠΊΠΎ Π² Π½ΠΎΡΠΌΠ°Π»ΡΠ½ΡΡ ΡΠΊΠ°Π½ΡΡ , Π½ΠΎ ΠΈ Π² ΡΠΈΡΡΠ΅ΠΌΠ΅ΠΌΠ°ΠΊΡΠΎΡΠ°Π³-ΠΎΠΏΡΡ ΠΎΠ»Π΅Π²Π°Ρ ΠΊΠ»Π΅ΡΠΊΠ°. ΠΠΎΠΊΠ°Π·Π°Π½ΠΎ, ΡΡΠΎ Π² ΠΎΡΠ½ΠΎΠ²Π΅ ΡΡΠΈΡ Π²Π·Π°ΠΈΠΌΠΎΠΎΡΠ½ΠΎΡΠ΅Π½ΠΈΠΉ ΡΠ°ΠΊΠΆΠ΅ Π»Π΅ΠΆΠΈΡ ΡΠΏΠΎΡΠΎΠ±Π½ΠΎΡΡΡ ΠΌΠ°ΠΊΡΠΎΡΠ°Π³ΠΎΠ² ΠΎΠ±ΡΠ°Π·ΠΎΠ²ΡΠ²Π°ΡΡ Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈ Π°ΠΊΡΠΈΠ²Π½ΡΠ΅ ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΡ… Π§ΠΈΡΠ°ΡΡ Π΅ΡΡ >
- Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅
- ΠΡΠ΄Π΅ΡΠΆΠΊΠ°
- ΠΠΈΡΠ΅ΡΠ°ΡΡΡΠ°
- ΠΡΡΠ³ΠΈΠ΅ ΡΠ°Π±ΠΎΡΡ
- ΠΠΎΠΌΠΎΡΡ Π² Π½Π°ΠΏΠΈΡΠ°Π½ΠΈΠΈ
Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅
- L ΠΠΠΠΠ ΠΠΠ’ΠΠ ΠΠ’Π£Π Π«
- 1. 1. ΠΠΏΠΎΠ»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½Ρ (ΠΎΠ±ΡΠΈΠ΅ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½ΠΈΡ)
- 1. 1. 1. ΠΠΏΠΎΠ»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½ A-I (ΡΡΡΡΠΊΡΡΡΠ°, ΠΌΠ΅ΡΠ°Π±ΠΎΠ»ΠΈΠ·ΠΌ, ΡΠ²ΠΎΠΉΡΡΠ²Π°)
- 1. 1. 2. ΠΠΏΠΎΠ»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½ Π (ΡΡΡΡΠΊΡΡΡΠ°, ΠΌΠ΅ΡΠ°Π±ΠΎΠ»ΠΈΠ·ΠΌ, ΡΠ²ΠΎΠΉΡΡΠ²Π°)
- 1. 2. ΠΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΡ ΠΏΠΎΠ³Π»ΠΎΡΠ΅Π½ΠΈΡ Π»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½ΠΎΠ² ΠΊΠ»Π΅ΡΠΊΠ°ΠΌΠΈ
- 1. 2. 1. Π, Π-ΡΠ΅ΡΠ΅ΠΏΡΠΎΡΡ
- 1. 2. 2. Π‘ΠΊΠ΅Π²Π΅Π½Π΄ΠΆΠ΅Ρ-ΡΠ΅ΡΠ΅ΠΏΡΠΎΡΡ Π΄Π»Ρ ΠΠΠΠ ΠΊΠ»Π°ΡΡΠ° Π
- 1. 2. 3. ΠΠΠΠ-ΡΠ΅ΡΠ΅ΠΏΡΠΎΡΠ½ΡΠΉ ΠΏΡΡΡ
- 1. 2. 4. Π‘ΠΊΡΠ²Π΅Π½Π΄ΠΆΠ΅Ρ-ΡΠ΅ΡΠ΅ΠΏΡΠΎΡΡ Π΄Π»Ρ ΠΠΠΠ ΠΊΠ»Π°ΡΡΠ° Π
- 1. 2. 5. ΠΠ’Π -ΡΠ²ΡΠ·ΡΠ²Π°ΡΡΠΈΠΉ ΠΊΠ°ΡΡΠ΅ΡΠ½ΡΠΉ ΡΡΠ°Π½ΡΠΏΠΎΡΡΠ΅Ρ («ΠΠΠ‘-Π±Π΅Π»ΠΎΠΊ»)
- 1. 1. ΠΠΏΠΎΠ»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½Ρ (ΠΎΠ±ΡΠΈΠ΅ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½ΠΈΡ)
- 3. 1. Π‘ΡΡΡΠΊΡΡΡΠ½ΠΎ-ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΡΠ΅ Π²Π·Π°ΠΈΠΌΠΎΠΎΡΠ½ΠΎΡΠ΅Π½ΠΈΡ ΠΊΠ»Π΅ΡΠΎΠΊ ΠΏΠ΅ΡΠ΅Π½ΠΎΡΠ½ΠΎΠ³ΠΎ ΡΠΈΠ½ΡΡΠΎΠΈΠ΄Π°
- 3. 4. Π ΠΎΠ»Ρ Π°ΠΏΠΎΠ»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½Π° Π Π² ΡΠ΅Π³ΡΠ»ΡΡΠΈΠΈ Π±ΠΈΠΎΡΠΈΠ½ΡΠ΅Π·Π° Π±Π΅Π»ΠΊΠ° ΠΈ Π½ΡΠΊΠ»Π΅ΠΈΠ½ΠΎΠ²ΡΡ ΠΊΠΈΡΠ»ΠΎΡ Π² ΠΊΡΠ»ΡΡΡΡΠ΅ Π½ΠΎΡΠΌΠ°Π»ΡΠ½ΡΡ Π³Π΅ΠΏΠ°ΡΠΎΡΠΈΡΠΎΠ² ΠΈ Π² ΠΊΠ»Π΅ΡΠΊΠ°Ρ Π°ΡΡΠΈΡΠ½ΠΎΠΉ Π³Π΅ΠΏΠ°ΡΠΎΠΌΡ ΠΡΠ»ΠΈΡ Π°
Π‘ΠΏΠΈΡΠΎΠΊ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
- ΠΠ°Π±ΠΈΡΠ΅Π² Π.Π. Π Π΅ΡΠ΅ΠΏΡΠΎΡΡ ΠΌΠ΅Ρ Π°Π½ΠΈΠ·ΠΌΡ Π΄Π΅ΠΉΡΡΠ²ΠΈΡ ΠΏΠΎΠ»ΠΎΠ²ΡΡ Π³ΠΎΡΠΌΠΎΠ½ΠΎΠ² ΠΌΠΎΠΆΠ΅Ρ Π»ΠΈ ΡΠ΅ΡΠ΅ΠΏΡΠΎΡ ΡΠ°Π±ΠΎΡΠ°ΡΡ Π±Π΅Π· Π»ΠΈΠ³Π°Π½Π΄Π°?// ΠΡΠΎΠ±Π»Π΅ΠΌΡ ΠΠ½Π΄ΠΎΠΊΡΠΈΠ½ΠΎΠ»ΠΎΠ³ΠΈΠΈ.-2006.-Π’.52.-№ 1.-Π‘.32−38.
- ΠΠ΅Π»ΠΎΠ²Π° Π.Π., ΠΠ³Π»ΠΎΠ±Π»ΠΈΠ½Π° Π. Π., ΠΠ΅Π»ΠΎΠ² A.A., ΠΡΡ Π°ΡΡΡΠΊ Π. Π. ΠΡΠΎΡΠ΅ΡΡΡ ΠΌΠΎΠ΄ΠΈΡΠΈΠΊΠ°ΡΠΈΠΈ Π»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½ΠΎΠ², ΡΠΈΠ·ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠ°Ρ ΠΈ ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠ°Ρ ΡΠΎΠ»Ρ ΠΌΠΎΠ΄ΠΈΡΠΈΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ Π»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½ΠΎΠ²// ΠΠΎΠΏΡΠΎΡΡ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΎΠΉ Ρ ΠΈΠΌΠΈΠΈ.-2000.-Π’.46.-№ 1 .-Π‘. 12−19.
- ΠΠΎΠ»ΡΠ΄Π±Π΅ΡΠ³ Π.Π., ΠΡΠ³Π°ΠΉ A.M., Π¨Π°Ρ ΠΎΠ² Π. Π. ΠΠ΅ΡΠΎΠ΄Ρ ΠΊΡΠ»ΡΡΡΡΡ ΡΠΊΠ°Π½ΠΈ Π² Π³Π΅ΠΌΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΈ. Π’ΠΎΠΌΡΠΊ: ΠΠ·Π΄-Π²ΠΎ Π’ΠΎΠΌ. Π£Π½-ΡΠ°, 1992.-264Ρ.
- ΠΠ»ΠΈΠΌΠΎΠ² Π.Π. ΠΠ±ΠΌΠ΅Π½ Π»ΠΈΠΏΠΈΠ΄ΠΎΠ² ΠΈ Π»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ΄ΠΎΠ² ΠΈ Π΅Π³ΠΎ Π½Π°ΡΡΡΠ΅Π½ΠΈΡ// Π‘Π°Π½ΠΊΡ-ΠΠ΅ΡΠ΅ΡΠ±ΡΡΠ³.-1999.-512Ρ.
- ΠΠ°ΠΊΠΎΠ²ΠΈΡ ΠΠΆ. ΠΡΠ½ΠΎΠ²Ρ ΡΠ»ΡΠΎΡΠ΅ΡΡΠ΅Π½ΡΠ½ΠΎΠΉ ΡΠΏΠ΅ΠΊΡΡΠΎΡΠΊΠΎΠΏΠΈΠΈ// ΠΠΎΡΠΊΠ²Π°. ΠΠΈΡ.-1986.-496Ρ.
- ΠΠΈΠΌΡΠΎΡΠΈΡΡ. ΠΠ΅ΡΠΎΠ΄Ρ. ΠΠΎΠ΄ ΡΠ΅Π΄Π°ΠΊΡΠΈΠ΅ΠΉ ΠΠΆ. ΠΠ»Π°ΡΡΠ°// ΠΠΎΡΠΊΠ²Π°. ΠΠΈΡ.-1990.-Π‘.36−39.
- ΠΡΡΠ΅ΡΠΌΠ°Π½ Π.Π. ΠΠ΅ΡΠΎΠ΄Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ Π±Π΅Π»ΠΊΠΎΠ² ΠΈ Π½ΡΠΊΠ»Π΅ΠΈΠ½ΠΎΠ²ΡΡ ΠΊΠΈΡΠ»ΠΎΡ. ΠΠ»Π΅ΠΊΡΡΠΎΡΠΎΡΠ΅Π· ΠΈ ΡΠ»ΡΡΡΠ°ΡΠ΅Π½ΡΡΠΈΡΡΠ³ΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅// ΠΠΎΡΠΊΠ²Π°, ΠΠ°ΡΠΊΠ°.-1981.-288Ρ.
- ΠΠ°Π½ΠΈΠ½ Π.Π., ΠΠΎΠ»ΡΠΊΠΎΠ² Π. Π. ΠΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ΄Ρ: ΡΠΎΡΡΠ°Π², ΡΡΡΡΠΊΡΡΡΠ°, ΡΠ²ΠΎΠΉΡΡΠ²Π°// ΠΡΠ»Π». Π‘Π ΠΠΠ Π‘Π‘Π‘Π .-1987.-№ 3.-Π‘. 22−30.
- ΠΠ°Π½ΠΈΠ½ Π.Π., ΠΠΈΡΡΠΊΠΈΠ½Π° Π. Π., ΠΠΎΠ»ΡΠΊΠΎΠ² Π. Π. ΠΠΎΠ»ΠΈΡΠ΅ΡΡΠ²Π΅Π½Π½Π°Ρ Ρ Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΡΡΠΈΠΊΠ° Π²Π·Π°ΠΈΠΌΠΎΠ΄Π΅ΠΉΡΡΠ²ΠΈΡ Π»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½ΠΎΠ² ΡΡΠ²ΠΎΡΠΎΡΠΊΠΈ ΠΊΡΠΎΠ²ΠΈ ΡΠΎ ΡΡΠ΅ΡΠΎΠΈΠ΄Π½ΡΠΌΠΈ Π³ΠΎΡΠΌΠΎΠ½Π°ΠΌΠΈ// ΠΡΠ». ΡΠΊΡΠΏ. Π±ΠΈΠΎΠ». ΠΈ ΠΌΠ΅Π΄.-1992.-Π’.112.-Π7.-Π‘.34−36.
- ΠΠ°Π½ΠΈΠ½ Π.Π., ΠΠΎΠ»ΡΠΊΠΎΠ² Π. Π., ΠΡΠ·ΡΠΌΠ΅Π½ΠΊΠΎ Π. Π., ΠΠΎΡΠ΅ΡΡΠ΅Π²Π° Π. Π., Π‘ΠΊΡΡΠ»Ρ Π. Π¨. ΠΠ±Π½Π°ΡΡΠΆΠ΅Π½ΠΈΠ΅ Π°ΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½Π° A-1-ΠΈΠΌΠΌΡΠ½ΠΎΡΠ΅Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ Π² Ρ ΡΠΎΠΌΠ°ΡΠΈΠ½Π΅ ΡΠ΄Π΅Ρ Π³Π΅ΠΏΠ°ΡΠΎΡΠΈΡΠΎΠ² ΠΊΡΡΡ// ΠΠΈΠΎΡ ΠΈΠΌΠΈΡ .-1992.-Π’.57.-№ 6.-Π‘.-826−832.
- ΠΠ°Π½ΠΈΠ½ J1.E., Π£ΡΡΠ½ΠΈΠ½ Π. Π€., Π₯Π°ΡΡΠΊΠΎΠ²ΡΠΊΠΈΠΉ A.B., Π’ΡΡΠ±ΠΈΡΠΈΠ½Π° Π. Π. Π ΠΎΠ»Ρ ΠΊΠ»Π΅ΡΠΎΠΊ ΠΡΠΏΡΠ΅ΡΠ° Π² ΡΠ΅Π³ΡΠ»ΡΡΠΈΠΈ Π±ΠΈΠΎΡΠΈΠ½ΡΠ΅Π·Π° Π±Π΅Π»ΠΊΠ° Π² Π³Π΅ΠΏΠ°ΡΠΎΡΠΈΡΠ°Ρ // ΠΠΎΠΏΡ. ΠΌΠ΅Π΄. Ρ ΠΈΠΌ.-1993 .-Π’.40.-№ 4.-Π‘.6−8.
- ΠΠ°Π½ΠΈΠ½ Π.Π., Π―Π²Π»Π΅Π½ΠΈΠ΅ ΡΡΠΈΠΌΡΠ»ΡΡΠΈΠΈ ΡΠ΅Π·ΠΈΠ΄Π΅Π½ΡΠ½ΡΠΌΠΈ ΠΌΠ°ΠΊΡΠΎΡΠ°Π³Π°ΠΌΠΈ Π±ΠΈΠΎΡΠΈΠ½ΡΠ΅Π·Π° Π±Π΅Π»ΠΊΠ° Π² ΠΏΠ°ΡΠ΅Π½Ρ ΠΈΠΌΠ½ΡΡ ΠΊΠ»Π΅ΡΠΊΠ°Ρ ΠΎΡΠ³Π°Π½ΠΎΠ² ΠΈ ΡΠΊΠ°Π½Π΅ΠΉ Π² ΠΏΡΠΎΡΠ΅ΡΡΠ΅ ΡΠ΅Π³Π΅Π½Π΅ΡΠ°ΡΠΈΠΈ// ΠΡΠ»Π». Π‘Π Π ΠΠΠ.-1998.- № 3.-Π‘.11−23.
- ΠΠ°Π½ΠΈΠ½ Π.Π., Π£ΡΡΠ½ΠΈΠ½ Π. Π€., Π₯Π°ΡΡΠΊΠΎΠ²ΡΠΊΠΈΠΉ A.B., ΠΠΎΡΠ΅ΡΡΠ΅Π²Π° Π. Π. ΠΠ»ΠΈΡΠ½ΠΈΠ΅ Π»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½ΠΎΠ² Π²ΡΡΠΎΠΊΠΎΠΉ ΠΏΠ»ΠΎΡΠ½ΠΎΡΡΠΈ ΠΈ Π³ΠΈΠ΄ΡΠΎΠΊΠΎΡΡΠΈΠ·ΠΎΠ½Π° Π½Π° ΠΏΡΠΎΠ΄ΡΠΊΡΠΈΡ Π°ΠΏΠΎΠ»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½Π° Π ΠΊΠ»Π΅ΡΠΊΠ°ΠΌΠΈ ΠΡΠΏΡΠ΅ΡΠ°// ΠΡΠ»Π». ΡΠΊΡΠΏ. Π±ΠΈΠΎΠ». ΠΌΠ΅Π΄.-1998.-Π’.126.-№ 7.-Π‘.43−45.
- ΠΠ°Π½ΠΈΠ½ Π.Π., ΠΠ°ΠΊΡΠΈΠΌΠΎΠ² Π. Π€., ΠΠΎΡΠΎΡΡΡΡΠ΅Π²ΡΠΊΠ°Ρ Π. Π. ΠΠ»ΠΈΡΠ½ΠΈΠ΅ Π³Π»ΡΠΊΠΎΠΊΠΎΡΡΠΈΠΎΠΊΠΈΠ΄ΠΎΠ² ΠΈ Π»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½ΠΎΠ² Π²ΡΡΠΎΠΊΠΎΠΉ ΠΏΠ»ΠΎΡΠ½ΠΎΡΡΠΈ Π½Π° Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΡΠ΄Π΅ΡΠ½ΠΎΠ³ΠΎ Π°ΠΏΠΏΠ°ΡΠ°ΡΠ° Π³Π΅ΠΏΠ°ΡΠΎΡΠΈΡΠΎΠ²// ΠΡΠ»Π». ΡΠΊΡΠΏΠ΅Ρ. Π±ΠΈΠΎΠ». ΠΈ ΠΌΠ΅Π΄.-1999.-Π’.128.-№ 12.-Π‘.650−653.
- ΠΠ°Π½ΠΈΠ½ Π.Π., Π ΡΡΡΠΊΠΈΡ Π. Π‘., ΠΠΎΠ»ΡΠΊΠΎΠ² Π. Π. ΠΠ±Π½Π°ΡΡΠΆΠ΅Π½ΠΈΠ΅ ΠΈΠΌΠΌΡΠ½ΠΎΡΠ΅Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΠΊ Π°ΠΏΠΎΠ»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½Π°ΠΌ A-I, Π ΠΈ Π Π² ΡΠ΄ΡΠ°Ρ ΠΊΠ»Π΅ΡΠΎΠΊ ΡΠΊΠ°Π½Π΅ΠΉ ΠΊΡΡΡ// ΠΠΈΠΎΡ ΠΈΠΌΠΈΡ.-2000.-Π’.65.- Π.12, — Π‘.1684−1689.
- ΠΠ°Π½ΠΈΠ½, Π.Π., Π₯ΠΎΡΠ΅Π½ΠΊΠΎ Π. Π., Π£ΡΡΠ½ΠΈΠ½ Π. Π€. Π ΠΎΠ»Ρ Π°ΠΏΠΎΠ»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½Π° A-I Π² Π°ΠΊΡΠΈΠ²Π°ΡΠΈΠΈ Π±ΠΈΠΎΡΠΈΠ½ΡΠ΅Π·Π° Π±Π΅Π»ΠΊΠ° ΠΈ ΠΠΠ Π² Π³Π΅ΠΏΠ°ΡΠΎΡΠΈΡΠ°Ρ ΠΏΠΎΠ΄ Π²Π»ΠΈΡΠ½ΠΈΠ΅ΠΌ ΡΡΠ΅ΡΠΎΠΈΠ΄Π½ΡΡ Π³ΠΎΡΠΌΠΎΠ½ΠΎΠ²// ΠΡΠ». ΡΠΊΡΠΏ. Π±ΠΈΠΎΠ». ΠΈ ΠΌΠ΅Π΄. 2001.-Π’. 131.- № 1.-Π‘.63 -65.
- ΠΠ°Π½ΠΈΠ½ Π.Π., ΠΠ°ΠΊΡΠΈΠΌΠΎΠ² Π. Π€., Π₯ΠΎΡΠ΅Π½ΠΊΠΎ Π. Π., ΠΠΎΡΠΎΡΡΡΡΠ΅Π²ΡΠΊΠ°Ρ Π.Π. Π‘ΡΡΡΠΊΡΡΡΠ½ΠΎ-ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΡΠ΅ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΡ Π² Π³Π΅ΠΏΠ°ΡΠΎΡΠΈΡΠ°Ρ ΠΈ ΠΊΠ»Π΅ΡΠΊΠ°Ρ
- ΠΡΠΏΡΠ΅ΡΠ° ΠΏΡΠΈ ΡΠΎΠ²ΠΌΠ΅ΡΡΠ½ΠΎΠΌ Π΄Π΅ΠΉΡΡΠ²ΠΈΠΈ Π³Π»ΡΠΊΠΎΠΊΠΎΡΡΠΈΠΊΠΎΠΈΠ΄ΠΎΠ² ΠΈ Π»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½ΠΎΠ² Π½ΠΈΠ·ΠΊΠΎΠΉ ΠΏΠ»ΠΎΡΠ½ΠΎΡΡΠΈ// Π¦ΠΈΡΠΎΠ»ΠΎΠ³ΠΈΡ.-2002.-Π’.43.-β.12.-Π‘.1150−1158.
- ΠΠ°Π½ΠΈΠ½ J1.E., ΠΠ°Ρ Π°ΡΡΠΊΠΎΠ²Π°, ΠΡΠ»ΡΠ΅Π²Π° Π. Π€. Π ΠΎΠ»Ρ Π»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½ΠΎΠ² ΠΊΠ°ΠΊ ΡΡΠ°Π½ΡΠΏΠΎΡΡΠ½ΡΡ ΡΠΎΡΠΌ ΠΊΡΠ΅Π½ΠΎΠ±ΠΈΠΎΡΠΈΠΊΠΎΠ² Π² ΠΈΠ½Π΄ΡΠΊΡΠΈΠΈ ΡΠ΅ΡΠΌΠ΅Π½ΡΠΎΠ² ΠΌΠΎΠΊΡΠΎΡΠΎΠΌΠ°Π»ΡΠ½ΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌΡ// ΠΡΠ». ΠΠΊΡΠΏ. ΠΠΈΠΎΠ». ΠΠ΅Π΄.-2002.-Π’.132.-№ 3.-Π‘.289−291.
- ΠΠ°Π½ΠΈΠ½ Π.Π., Π’ΡΠ·ΠΈΠΊΠΎΠ² Π€. Π., Π’ΡΠ·ΠΈΠΊΠΎΠ²Π° H.A., ΠΠΈΠΌΠ°ΡΡΠ΄ΠΈΠ½ΠΎΠ²Π° Π. Π., ΠΠΎΠ»ΡΠΊΠΎΠ² Π. Π. ΠΠ·Π°ΠΈΠΌΠΎΠ΄Π΅ΠΉΡΡΠ²ΠΈΠ΅ ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΠ° ΡΠ΅ΡΡΠ°Π³ΠΈΠ΄ΡΠΎΠΊΠΎΡΡΠΈΠ·ΠΎΠ»-Π°ΠΏΠΎΠ»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½ A-I Ρ ΡΡΠΊΠ°ΡΠΈΠΎΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΠΠ ΠΈ ΠΎΠ΄Π½ΠΎΡΠ΅ΠΏΠΎΡΠ΅ΡΠ½ΡΠΌΠΈ ΠΎΠ»ΠΈΠ³ΠΎΠ½ΡΠΊΠ»Π΅ΠΎΡΠΈΠ΄Π°ΠΌΠΈ// ΠΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½Π°Ρ Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡ.-2002.-Π’.36.-№ 1 .-Π‘.96−102.
- ΠΠ°Π½ΠΈΠ½ Π.Π. ΠΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΡΠ΅ ΠΌΠ΅Ρ Π°Π½ΠΈΠ·ΠΌΡ ΡΠ΅Π³ΡΠ»ΡΡΠΈΠΈ ΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠΉ ΠΏΡΠΎΠ»ΠΈΡΠ΅ΡΠ°ΡΠΈΠΈ ΠΈ ΠΎΠΏΡΡ ΠΎΠ»Π΅Π²ΠΎΠ³ΠΎ ΡΠΎΡΡΠ°// ΠΡΠ». Π‘Π Π ΠΠΠ.-2002.-№ 2.-Π‘. 8−14.
- ΠΠ°Π½ΠΈΠ½ Π.Π., Π₯ΠΎΡΠ΅Π½ΠΊΠΎ Π. Π. Π ΠΎΠ»Ρ ΡΠ΅Π·ΠΈΠ΄Π΅Π½ΡΠ½ΡΡ ΠΌΠ°ΠΊΡΠΎΡΠ°Π³ΠΎΠ² Π² ΡΠ΅Π³ΡΠ»ΡΡΠΈΠΈ Π±ΠΈΠΎΡΠΈΠ½ΡΠ΅Π·Π° ΠΠΠ ΠΈ Π±Π΅Π»ΠΊΠ° Π² ΠΊΠ»Π΅ΡΠΊΠ°Ρ Π°ΡΡΠΈΡΠ½ΠΎΠΉ Π³Π΅ΠΏΠ°ΡΠΎΠΌΡ ΠΌΠ΅ΡΠ΅ΠΉ Π»ΠΈΠ½ΠΈΠΈ A/Sn (A)// ΠΠΎΠΏΡΠΎΡΡ ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΠΈ.-2003.-Π’.49, № 4.-Π‘.472−475.
- ΠΠ°Π½ΠΈΠ½ Π.Π., Π’ΡΠ·ΠΈΠΊΠΎΠ² Π€. Π., Π’ΡΠ·ΠΈΠΊΠΎΠ²Π° H.A., ΠΠΎΠ»ΡΠΊΠΎΠ² Π. Π. ΠΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠΈ Π²Π·Π°ΠΈΠΌΠΎΠ΄Π΅ΠΉΡΡΠ²ΠΈΡ ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΠΎΠ² ΠΊΠΎΡΡΠΈΠ·ΠΎΠ» Π°ΠΏΠΎΠ»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½ A-I ΠΈ ΡΠ΅ΡΡΠ°Π³ΠΈΠ΄ΡΠΎΠΊΠΎΡΡΠΈΠ·ΠΎΠ» — Π°ΠΏΠΎΠ»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½ A-I Ρ ΡΡΠΊΠ°ΡΠΈΠΎΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΠΠ// ΠΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½Π°Ρ Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡ.-2006.-Π’.40.-№ 2.-Π‘.300−309.
- ΠΠΎΠ»ΡΠΊΠΎΠ² Π.Π. ΠΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½Ρ ΠΏΠ»Π°Π·ΠΌΡ ΠΊΡΠΎΠ²ΠΈ: ΡΡΠ°Π½ΡΠΏΠΎΡΡΠ½Π°Ρ ΡΠΈΡΡΠ΅ΠΌΠ° Π΄Π»Ρ ΠΊΡΠ΅Π½ΠΎΠ±ΠΈΠΎΡΠΈΠΊΠΎΠ² ΠΈ Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈ Π°ΠΊΡΠΈΠ²Π½ΡΡ Π²Π΅ΡΠ΅ΡΡΠ²// ΠΡΠ». Π‘Π Π ΠΠΠ,-1998.-T.3.-C.23−29.
- ΠΠΎΠ»ΡΠΊΠΎΠ² Π.Π., ΠΠ°Π½ΠΈΠ½ Π. Π., ΠΠΏΠΎΠ»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½ Π: ΡΡΡΡΠΊΡΡΡΠ° ΠΈ ΡΡΠ½ΠΊΡΠΈΠΈ// Π£ΡΠΏΠ΅Ρ ΠΈ ΡΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΠΉ Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΠΈ.-1998.-Π’.118.-№ 6.-Π‘.743−753.
- ΠΠΎΠ»ΡΠΊΠΎΠ² Π.Π., ΠΠ°Π½ΠΈΠ½ Π. Π. ΠΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½ΠΎΠ²Π°Ρ ΡΠ΅Π³ΡΠ»ΡΡΠΈΡ Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ ΠΏΡΠΎΡΠ΅ΡΡΠΎΠ²// Π£ΡΠΏΠ΅Ρ ΠΈ ΡΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΠΉ Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΠΈ.-2000.-Π’.120.-Π‘.275−282.
- ΠΠΎΡΠΊΠΎΠ² Π.Π., ΠΡΠ΅Π²Π° Π’. Π. Π‘ΡΠΌΠ΅Π½ΠΊΠΎΠ²Π° Π.Π., ΠΠ°Π½ΠΈΠ½ Π. Π. Π ΠΎΠ»Ρ Π»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅Π½ΠΈΠ½ΠΎΠ² Π² ΡΠ²ΡΠ·ΡΠ²Π°Π½ΠΈΠΈ ΠΏΠΎΠ»ΠΈΡΠ°Ρ Π°ΡΠΈΠ΄ΠΎΠ² Π±Π°ΠΊΡΠ΅ΡΠΈΠ°Π»ΡΠ½ΠΎΠ³ΠΎ ΠΈΠ΄ΡΠΎΠΆΠΆΠ΅Π²ΠΎΠ³ΠΎ ΠΏΡΠΎΠΈΡΡ ΠΎΠΆΠ΄Π΅Π½ΠΈΡ// ΠΡΠ». Π‘Π Π ΠΠΠ.-2007.-Π’.123.-№ 1.-Π‘.67−70.
- Π¨Π°ΡΠΊΠΈΠ½ Π. ΠΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΡ Π Π, ΠΠΠ, ΠΈ Π±Π΅Π»ΠΊΠ° Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΠΌΠ΅ΡΠ΅Π½ΡΡ ΠΏΡΠ΅Π΄ΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΈΠΊΠΎΠ² ΠΈ ΠΏΠΎΡΠ»Π΅Π΄ΡΡΡΠ΅Π³ΠΎ Ρ ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΡΠ°ΠΊΡΠΈΠΎΠ½ΠΈΡΠΎΠ²Π°Π½ΠΈΡ// Π ΠΊΠ½.: ΠΠ΅ΡΠΎΠ΄Ρ Π²ΠΈΡΡΡΠΎΠ»ΠΎΠ³ΠΈΠΈ ΠΈ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎΠΉ Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΠΈ.- ΠΠΈΡ, Π., 1972.- Π‘. 184−193.
- Abril E.R., Rybski J.A., Scuderi P., Watson R.R. Beta-carotene stimulates human leukocytes to secrete a novel cytokine// J. Leukoc. Biol.-1989.-V.45(3).-P.255−261.
- Acton S.L., Kozarsky K.F., Rigotti A. The HDL receptor SR-BI: a new therapeutic target for atherosclerosis?// Mol. Med. Today.-1999.-V.5.-P.518−524.
- Alaupovic P. Apoliproproteins and lipoproteins// Atherosclerosis.-1971.-V.2.-P. 141−146.
- Attalah N.A., Lata G.F. Steroid-protein interactions studied by fluorescence quenching// Biochem. Biophys. Acta.-1968.-V.168.-N.2.-P.321−333.
- Attie A.D., Kastelein J.P., Hayden M.R. Pivotal role of ABCA1 in reverse cholesterol transport influencing HDL levels and susceptibility to atherosclerosis// J. Lipid. Res.-2001.-V.42.- P.1717−1726.
- Basu S.K., Brown M.S., Ho Y.K., Havel R.J., Goldstein J.L. Mouse macrophages synthesize and secrete a protein resembling apolipoprotein E//Science.-1983.-V.78.- P.7545−7549.
- Basu S.K., Goldstein J.L., Brown M.S. Independent pathway for secretion of cholesterol and apolipoprotein E by macrophages// Science.-1983 .-V.219.-P. 871 -873.
- Blanco-Vaca F., Escola-Gil J.C., Martin-Campos J.M., Julve J. Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein// J. Lipid Res.-2001.-V.42(l 1).-P. 1727−1739.
- Blue M. L., Williams D.L., Zucker D., Alan K.S., Blum C. Apolipoprotein E synthesis in human kidney, adrenal gland and liver// Proc.Natl.Acad.Sci.USA.-1983.-V.80.-P.283−287.
- Bojanovski M., Gregg K.E., Wilson D.M., Brewer H.B. Competitive enzyme-linked immunosorbent assay (ELISA) for the quantitation of apoprotein A-I using a monoclonal antibody// Clin.Chim.Acta.- 1988.-V.178.- P.159−169
- Borst P., Elferink R.O. Mammalian ABC transporters in health and disease // Annu. Rev. Biochem.-2002.-V.71.-P.537−592.
- Brand K., Mackman N., Curtiss L. Interferon-gamma inhibits macrophage apolipoprotein-E production by posttranslational mechanisms// J.Clin.Invest.- 1993.-V.91.-P.2031−2039.
- Breslow J.L. Human apolipoproteins: molecular biology and genetic variation// Ann.Rev.Biochem.-1985.-V.54.- P.699−727.
- Breslow J. Apolipoprotein genetic variation and human disease// Physiol.-1988. Rev. 68.-P.85−132.
- Brewer H.B., Fairwell T., LaRue A., Ronan R. et al. The amino acid sequence of human apo A-I, an apolipoprotein isolated from high density lipoproteins// Biochem.Biophys.Res. Communs.- 1978, — V.80.- N.3.- P.623−630.
- Brodeur M. R, Luangrath V., Bourret G., Falstrault L., Brissette L. Physiological importance of SR-BI in the in vivo metabolism of human HDL and LDL in male and female mice// J. Lipid. Res.-2005.-V.46.-P.687−696.
- Brouwer D.A., van Doormaal J.J., Muskiet F.A. Clinical chemistry of common apolipoprotein E isoforms// J. Chromatogr. B. Biomed.-1996.-V.678(l).-P.23−41.
- Brown M.S., Goldstein J.L. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor// Cell.- 1997.-V.89(3).-P.331−40.
- Calvo C., Ulloa N., Del-Pozo R., Verdugo C. Decreased activation of lecithin: cholesterol acyltrasferase by glycated apolipoprotein A-I// Eur.J.Clin.Chem.and Clin.Biochem.- 1993.-V.31.- P.217−220.
- Camejo G., Hurt-Camejo E., Rosengren B., Wiklund O., Lopez F., Bondjers G. Modification of cooper-catalized oxidation of low density lipoprotein by proteoglycans and glycosaminoglycans// J. Lipid Res.-1991.-V.32.- P. 1983−1992.
- Caruso A., Motolese M., Iacovelli L. et al. Inhibition of the canonical Wnt signaling pathway by apolipoprotein E4 in PC 12 cells// J. Neurochem. -2006. Vol.98. — № 2. — P.364 — 371.
- Cunha G.R., Bigsby R.M., Cooke P. S., Sugimura Y. Stromal-epithelial interactions in adult organs// Cell Differ.-1985.-V.17(3).-P. 137−148.
- Chapman M.J. Animal lipoproteins: chemistry, structure, and comparative aspects// J. Lipid Res.- 1980.- V.21.-P.789−853.
- Chen Y., Li R., Wang R., Liu Z. The significance of nuclear factor kappa Bp65 (NF kappa Bp65) expression on the vascular endothelial cells of rectum adenocarcinoma of human// Chinese.-2001.-V.32(2).-P.196−199.
- Clay M.A., Anantharamaiah G.M., Mistry M.J., Balasubramaniam A., Harmony J.A. Localization of a domain in apolipoprotein E with both cytostatic and cytotoxic activity// Biochemistry.-1995.-34(35).-P. 1 114 211 151.
- Clay M.A., Pyle D.H., Rye K.A., Barter P.J. Formation of spherical, reconstituted high density lipoproteins containing both apolipoproteins A-I and A-II is mediated by lecithin: cholesterol acyltransferase// J. Biol. Chem.-2000.-V.275.-P.9019−9025.
- Curtiss L., Edgington T. Identification of a lymphocyte surface receptor for low-density lipoprotein inhibition, an immunoregulatoryspecies of normal plasma low density lipoprotein// J.Clin.Invest.-1978.-V.61.-P.1298−1308.
- Curtiss L.K., Edgington T.Y. Immunochemical heterogeneity of human plasma high density lipoproteins identification with apolipoprotein A-I specific and A-II specific monoclonal — antibodies// J. Biol. Chem.- 1985.-V.260.- N.5.- P.2982−2993.
- Davidson N., Carlos R., Drewek M., Parmer T. Apolipoprotein gene expression in the rat is regulated in a tissue-specific manner by thyroid hormone// J. Lipid Res.-1988.-V.29.-P. 1511−1522.
- Davis C.G., Goldstein J.L., Sudhof T.C., Anderson R.G., Russell D.W., Brown M.S. Acid-dependent ligand dissociation and recycling of LDL receptor mediated by growth factor homology region// Nature.-1987.-V.326(6115).-P.760−765.
- Diederich W., Orso E., Drobnik W., Schmitz G. Apolipoprotein AI and HDL (3) inhibit spreading of primary human monocytes through a mechanism that involves cholesterol depletion and regulation of CDC42// Atherosclerosis. 2001 .-V. 159(2).-P.313−324.
- Dean M., Rzhetsky A., Allikmets R. The human ATP-binding cassette (ABC) transporter superfamily// Genome Res. 2001.-V. 11(7).-P.l 156−1166.
- Drayna D.T., McLean J.W., Wion K.L., Trent J.M., Drabkin H.A., awn R.M. Human apolipoprotein D gene: gene sequence, chromosome localization, and homology to la-globulin superfamily//DNA.- 1987.-V.6.-P. 199−214.
- Dyer, C.A.- Curtiss, L.K. A synthetic peptide mimic of plasma apolipoprotein-E that binds the LDL receptor// J. Biol.Chem.-1991.- V.266.-P.22 803−22 806.
- Elshourbagy N., Liao W., Mahley R., Taylor J. Apolipoprotein E mRNA in abundant in the brain and adrenals, as well, as the liver, and is present in other peripheral tissues of rats and marmosets// Proc.Natl.Acad.Sci.USA.-1985.-V.82.-P.203−207.
- Farkas M.H., Weisgraber K.H., Shepherd V.L., Linton M.F., Fazio S., Swift L.L. The recycling of apolipoprotein E and its amino-terminal 22 kDa fragment: evidence for multiple redundant pathways// J. Lipid Res.-2004.-V.45.-P. 1546−1554.
- Fazio S., Babaev V.R., Murray A.B., Hasty A.H., Carter K.J., Gleaves L.A., Atkinson J.B., Linton M.F. Increased atherosclerosis in C57BL/6 mice reconstituted with apolipoprotein E null macrophages// Proc. Natl. Acad. Sci. USA.-1997.-V.94.-P.4647−4652.
- Francke U., Brown M.S., Goldstein J.L. Assigment of the human gene for the low density lipoprotein receptor to chromo-some 19: synteny of a receptor, a ligand, and genetic disease// Proc.Natl.Acad.Sci.USA.- 1984.-V.81.- P.2826−2830.
- Fidge N.H. High density lipoprotein receptors, binding proteins, and ligands// J. Lipid. Res.-1999.-V.40.-P. 187−201.
- Fong B.S., Grego A.V., Angel A. Hypothyroidism reduces HDL binding to rat liver cells// Atherosclerosis.-1989.-V.79.-N.l. -P. 1−8.
- Fung W-P., Howlett G., Schreiber G. Structure and expression of the rat apolipoprotein E gene// J.Biol.Chem.-1986.-V.-261.-P.13 777−13 783.
- Furlaneto C.J., Ribeiro F.P., Hatanaka E., Souza G.M., Cassatella M.A., Campa A. Apolipoproteins A-I and A-II downregulate neutrophil functions//Lipids.-2002.-V.37(9).-P.925−928.
- Georghiou S., Thompson M., Mukhopadhyay A.K. Melittin-phospholipid interaction: evidence for melittin aggregation// Biochim. Biophys. Acta.- 1981.-V.642(2).-P.429−32.
- Ginsberg H.N. Lipoprotein physiology// Endocrinol. Metab. Clin. North. Am.-1998.-V.27(3).-P503−519.
- Glass C.K., Pittman R.C., Civen M., Steinberg D. Uptake of high-density lipoprotein-associated apoprotein A-I and cholesterol ester by 16 tissues of the rat in vivo and by adrenal cells and hepatocytes in vitro// J.Biol.Chem.- 1985.- V.260.-P.744−750.
- Goldstein J., Brown M. The low-density lipoprotein pahtway and its relation to atherosclerosis// Annu.Rev.Biochem.- 1977.- V.46.-P.897−930.
- Gordon J.I., Smith D.P., Andy R., Alpers D.H. et. al. The primary translation product of rat intestinal apolipoprotein AI mRNA is an unusual preprotein// J.Biol.Chem.- 1982.-V.257.- N.2.- P.971−978.
- Granot E, Eisenberg S. ApoE-3-specific metabolism of human plasma very low density lipoproteins in cultured J-774 macrophages// J. Lipid Res.-1990.-V.31(12).-P. :2133−2139.
- Greenberg S.M., Rebeck G.W., Vonsattel J.P., Gomez-Isla T., Hyman B.T. Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy// Ann Neurol.-1995.-V.38(2).-P.254−259.
- Hamilton R., Wong J., Guo L., Krisans S., Havel R. Apolipoprotein E localization in rat hepatocytes by immunogold labeling of cryothinsections // J. Lipid Res.- 1990.- V.31.-P.1589−1603.
- Hampton RY. Proteolysis and sterol regulation// Annu. Rev. Cell Dev. Biol.-2002.-V.18.-P.345−378.
- Han J., Mathison J.C., Ulevitch R.J. and Tobias P. S. Lipopolyaccharide (LPS) binding protein, truncated at lie-197, binds LPS but does not transfer LPS to CD 14// J. Biol. Chem.- 1994. -V.269.-P.8172−8175.
- Handwerger S., Myers S., Richards R. et al. Apolipoprotein A-I stimulates placental lactogen expression by human trophoblast cells // J. Endocrinol. 1995. — Vol.136. — (12). — P.5555 — 5560.
- Hatch F.T., Less R.S. Practical method for plasma lipoprotein analysis //Adv. Lipid Res.-1968.-V.6.-P.2−68.
- Hayashi M., Abe-Dohmae S., Okazaki M., Ueda K., Yokoyama S. Heterogeneity of high density lipoprotein generated by ABCA1 and ABCA7 // J. Lipid Res.-2005.-V.46.-P. 1703−1711.
- Herbert P.N., Shulman R.S., Levy R.I., Fredrickson D.S. Fractionation of the C-apoproteins from human plasma very low density lipoproteins// J. Biol Chem.- 1973 .-V.248(14).-P.4941−4946.
- Ho Y.Y., Deckelbaum R.J., Chen Y. et al. Apolipoprotein E inhibits serum-stimulated cell proliferation and enhances serum-independent cell proliferation// J. Biol. Chem. 2001. — Vol.276. — № 46. — P.43 455 — 43 462.
- Hui D., Harmony J., Innerarity T., Mahley R. Immunoregulatory plasma lipoproteins. Role of apoprotein E and apoprotein B// J.Biol.Chem.-1980.- V.225.- P. l 1775−11 781.
- Hui D., Innerarity T., Maley R. Lipoprotein binding to canine hepatocyte membranes. Metabolically distinct apo E and apo-B, E receptors// J. Biol. Chem.-1981.- V.256.- P.-5646−5655.
- Hussain M., Zanni E., Kelly M., Zannis V.O. Synthesis, modification, and flotation properties of rat hepatocyte apolipoproteins// Biochim. et biophys. acta. 1989.- V.1001.- P.90.
- Jain R.S., Quarfordt S.H. The carbohydrate content of apolipoprotein E from human very low density lipoproteins// Life Sci.-1979.-V.25(15).-P.1315−1323.
- Jakel H., Nowak M., Helleboid-Chapman A., Fruchart-Najib J., Fruchart J.C. Is apolipoprotein A5 a novel regulator of triglyceride-rich lipoproteins?// Ann. Med.-2006.-V.38.-βl.-P.2−10.
- Johnson W.J., Mahlberg F.H., Rothblat G.H., Phillips M.C. Cholesterol transport between cells and high-density lipoproteins// Biochim. Biophys. Acta.-1991.-V.85.-P.273−298.
- Jonas A., Steinmetz A., Churgay L. The number of amphipathic alpha-helical segments of apolipoprotein-A-I, apolipoprotein-E, and apolipoprotein
- A-IV determines the size and functional properties of their reconstituted lipoprotein particles// J.Biol.Chem.-1993.-V.268. P.1596−1602.
- Kashyap M.L., Barnhart R.L., Srivastava L.S., Perisutti G et al. Effects on dietary carbohydrate and fat on plasma lipoproteins and apolipoprotein C-II and C-III in healthy men// J. Lipid Res.- 1982.- V.23.-N.6.- P.877−886
- Kawano K., Qin S., Vieu C., Collet X., Jiang X.C. Role of hepatic lipase and scavenger receptor BI in clearing phospholipid/free cholesterol-rich lipoproteins in PLTP-deficient mice// Biochim. Biophys. Acta.-2002.-V.1583.-P.133−140.
- Kayden H., Maschio F., Trabar M. The secretion of apoprotein E by human monocyte-derived macrophages// Arch.Biochem.Biophys.- 1985.-V.239.- P.388−395.
- Kim M., Nakayama R., Manos P., Tomlinson J., Choi E., Ny J., Hotlen D. Regulation of apolipoprotein E synthesis andmRNA by diet and hormones//J. Lipid Res.-1989.- V.30.-N.5.-P.663−671.
- Kiss R.S., McManus D.C., Franklin V., Tan W.L., McKenzie A., Chimini G., Marcel Y.L. The lipidation by hepatocytes of human apolipoprotein A-I occurs by both ABCA1 -dependent and -independent pathways// J. Biol. Chem.-2003.-V.278.-P. 10 119−10 127.
- Kiss R.S., Marie J., Marcel Y.L. Lipid efflux in human and mouse macrophagic cells: evidence for differential regulation of phospholipid and cholesterol efflux//J. Lipid Res.-2005.-V.46.-P. 1877−1887.
- Kujiraoka T., Nanjee M.N., Oka T., Ito M., Nagano M., Cooke C.J., Takahashi S., Olszewski W.L., Wong J.S., Stepanova I.P., Hamilton R.L.,
- Egashira T., Hattori H., Miller N.E. Effects of intravenous apolipoprotein A-I/phosphatidylcholine discs on LCAT, PLTP, and CETP in plasma and peripheral lymph in humans// Arterioscler. Thromb. Vase. Biol.-2003.-V.23.-P.1653−1659.
- Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4// Nature. -1970.- V.227.-P.680−685.
- Lee J.Y., Parks J.S. ATP-binding cassette transporter AI and its role in HDL formation// Curr. Opin. Lipidol.-2005.-V.16(l).-P. 19−25.
- Leszczynski D.E., Schafer R.M. Metabolic conversion of six steroid hormones by human plasma high-density lipoprotein// Biochim. Biophys. Acta.-1991 .-V. 1083(1).-P. 18−28.
- Lewis C.E., Leek R., Harris A., McGee J.O. Cytokine regulation of angiogenesis in breast cancer: the role of tumor-associated macrophages// J. Leukoc. Biol.-1995.-V.57(5).-P.747−751. Review.
- Lichtor T. Gene expression of apolipoprotein E in human brain tumors// Neurosci. Lett.-1992.-V. 13 8(2).-P.287−290.
- Lin C.Y., Duan H.W., Mazzone T. Apolipoprotein E-dependent cholesterol efflux from macrophages: kinetic study and divergent mechanisms for endogenous versus exogenous apolipoprotein E// J. Lipid Research.-1999.- V.40.-P. 1618−1626.
- Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent// J. Biol. Chem. -1951. Vol.193. — P.265 — 275.
- Mahley R., Angelin B. Type III hyperlipoproteinemia: recent insights into the genetic defect of familial disbetalipoproteinemia// Adv.Intern.Med.-1984.-V.29.-P.385−411.
- Mahley R.W., Innerarity T.L., Rail S.C., Weisgraber K.H. Plasma lipoprotein: apolipoprotein structure and function// J. Lipid Res.- 1984.-V.25.- N.12.- P. 1277−1294.
- Major C.D., Wolf B.A. Interleukin-lbeta stimulation of c-Jun NH (2)-terminal kinase activity in insulin-secreting cells: evidence for cytoplasmic restriction// Diabetes.- 2001.-V.50(12).-P.2721−8.
- Mao S.J.T., Miller J.P., Gotto A.M., Sparrow J.T. The antigenic structure of apolipoprotein A-I in human high density lipoproteins. Radioimmynoassay using surface specific antibodies// J. Biol. Chem.-1980.- V.255.- N.8.- P.3448−3453.
- Marcel Y.L., Jewer D., Vesina C., Milthorp P. et al. Expression of human apo A-I epitopes in high density lipoprotein and in serum// J. Lipid Res.- 1987.- V.28.- N.7.- P.768−777.
- Mariash C., Oppenheimer J. Stimulation of malic enzyme formation in hepatocyte culture by metabolites// Metab. Clin. Exp.- 1983.-V.33.- P.545−552.
- Matsumoto A., Aburatani H., Shibasaki Y., Kodama T., Takaku F., Itakura H. Cloning and regulation of rat apolipoprotein B mRNA// Biochem.Biophys.Res.Commun.-1987,-V. 142.-P.92−99.
- Maziere C., Maziere J.-C., Salmon S., Auclair M., Mora J., Moreau M., Polonovski J. Cyclic AMP decreases LDL catabolism and cholesterol synthesis in the human hepatoma cell line HepG2// Biochem.Biophys.Res.Communs.- 1988, — V.156.-P.424−431.
- Mazzone, T. Apolipoprotein E secretion by macrophages: its potential physiological functions// Curr. Opin. Lipidol.-1996.-V.7.-P.303−307.
- Mc Conathy W.J., Alaupovic P. Studies on the isolation and partial characterization of apolipoprotein D and lipoprotein D of human plasma// Biochemistry.-1976.-V. 15(3).-P.515−520.
- Metzger S., Leff T., Breslow J. Nuclear factors AF-1 and C/EBP bind to the human apoB gene promoter and modulate its transcriptional activity in hepatic cells// J. Biol. Chem.- 1990.-V.265.-P.9978−9983.
- Meng Q.H., Calabresi L., Fruchart J.C., Marcel Y.L. Apolipoprotein AI domains involved in the activation of lecithin: cholesterol acyltransferase. Importance of the central domain// J. Biol. Chem.- 1993-V.268(23).-P. 1 696 616 973.
- Moore Z.W., Hui D.Y. Apolipoprotein E inhibition of vascular hyperplasia and neointima formation requires inducible nitric oxide synthase // J. Lipid Res. 2005. — Vol.46. — № 10. — P.2083 — 2090.
- Morin O., Normand C. Long-term maintenance of hepatocyte functional activity in co-culture: requirements for sinusoidal endothelial cells and dexamethasone// J. Cell Physiol.-1986.-V.129(l).-P.103−110.
- Mouchel Y, Lefrancois T, Fages C, Tardy M. Apolipoprotein E gene expression in astrocytes: developmental pattern and regulation// Neuroreport.-1995.-V.7(l).-P.205−208.
- Nathan B.P., Chang K.C., Bellosta S., Brisch E., Ge N., Mahley R.W., Pitas R.E. The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization// J. Biol. Chem.-1995.-V.270(34).-P. 19 791 -19 799.
- Niemi M., Hakkinen T., Karttunen T.J. et al. Apolipoprotein E and colon cancer. Expression in normal and malignat human intestine and effect on cultured human colonic adenocarcinoma cells// Eur. J. Intern. Med. 2002. — Vol.13. -№ 1.-P.37−43.
- Nofer J.R., Remaley A.T., Feuerborn R., Wolinnska I., Engel T., von Eckardstein A., Assmann G. Apolipoprotein A-I activates Cdc42 signaling through the ABCA1 transporter// J. Lipid Res.-2006.-V.47.-P.794−803.
- Nolte R.T., Atkinson D. Conformational analysis of apolipoprotein A-I and E-3 based on primary sequence and circular dichroism// Biophys. J.-1992.-V.63(5).-P. 1221 -39.
- Oram J.F. Molecular basis of cholesterol homeostasis: lessons from Tangier disease and ABCA1// Trends Mol Med.-2002.-V.8.-P.168−173.
- Panin L.E., Tuzikov F.V., Tuzikova N.A., Polyakov L.M. Application of the small-angle X-ray scattering technic for estimating structural changes in high density lipoproteins// Memb. and Cell Biol.-1996.-V.10.-N.l.-P.75−82.
- Panin L.E., Tuzikov F.V., Gimautdinova O.I. Tetrahydrocortisol -apolipoprotein A-I complex specifically interacts with eucaryotic DNA and GCC elements of genes//J. Steroid Biochem. Molecular Biol.-2003. -N.87.-P.-09−318.
- Panin L. E. Molecular mechanisms of interaction of THC-apoA-I complex with DNA and initiation of transcription// Progress in DNA Research. Nova Science Publishers Inc. N.Y.-2005.-P.1−38.
- Pedram A, Razandi M, Aitkenhead M, Hughes CC, Levin ER. Integration of the non-genomic and genomic actions of estrogen. Membrane-initiated signaling by steroid to transcription and cell biology// J. Biol. Chem. 2002.-V.277(52).-P.50 768−50 775.
- Pepe M.G., Curtiss L.K. Apolipoprotein E is a biologically active constituent of the normal immunoregulatory lipoprotein, LDL-In// J. Immunol.- 1986.-Vol.l36.-№ 10.-P.3716−3723.
- Phillips M.C., Johnson W.J., Rothblat G.H. Mechanisms and consequences of cellular cholesterol exchange and transfer// Biochim. Biophys. Acta.-1987.-V.24.-P.223−276.
- Pietras R. J, Szego C.M. Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells//Nature.- 1977/-V.265(5589).-P.69−72.
- Pitas R.E., Boyles J.K., Lee S.H., Fossamol D., Mahley R.W. Astrocytes synthetize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins// Biochim. Biophys. Acta. -1987.- V.917.- P.178−161.
- Pitas R.E., Weisgraber K.H., Boyles J.K., Lee S.H., Mahley R.W. Characterization of lipoproteins in human and canine cerebrospinal fluid// Fed.Proc.-1986.-V.45.-P.587.
- Qui Z., Hyman B.T., Rebeck G.W. Apolipoprotein E receptors mediate neurite outgrowth through activation of p44/42 mitogen-activated protein kinase in primary neurons// J. Biol. Chem. 2004. — Vol.279. — № 33. -P.34 948 — 34 956.
- Rajan V.P., Menon K.M. Metabolism of high-density lipoproteins in cultured rat luteal cells// Biochim. Biophys. Acta.-1987.-V.921(l).-P.25−37.
- Rail S.C., Weisgraber K.H., Mahley R.W. Human apolipoprotein E. The complete aminoacid sequence// J. Biol. Chem.- 1982.-V.257.-P.4171−4178.
- Reardon C.Q., Lan Y.F., Paik Y.K., Weisgraber K.H., Mahley R., Taylar J.W. expression of the human apolipoprotein E genein cultured mammalian cells//J. Biol. Chem.- 1988.- V.261.-P.9858- 9864.
- Rensen P.C., van Dijk M.C., Havenaar E.C., Bijsterbosch M.K., Kruijt J.K., van Berkel T.J. Selective liver targeting of antivirals by recombinant chylomicrons~a new therapeutic approach to hepatitis B// Nat. Med.-1995.-V.l (3).-P.221−225.
- Roberts I.S. The biochemistry and genetics of capsular polysaccharide production in bacteria//Annu. Rev. Microbiol.- 1996. -V.50.-P.285−315.
- Roheim P. S., Carey M., Forte T., Vega G.L. Apolipoproteinin human cerebrospinal fluid// Proc. Natl. Acad. Sci. USA.-1979.- V.76.- N.9.- P.4646−4649.
- Rothblat G.H., de la Llera-Moya M., Atger V., Kellner-Weibel G., Williams D.L., Phillips M.C. Cell cholesterol efflux: integration of old and new observations provides new insights// J. Lipid. Res.-1999.-V.40.-P.781−796.
- Rudling M.J., Collins P.V., Peterson C. Delivery of alcalinomycin A to human glioma cells in vitro by the low-density lipoprotein pathway// Cancer Res.- 1983.- V.43.- P.4600−4605.
- Schmitz G., Langmann T., Heimerl S. Role of ABCG1 and other ABCG family members in lipid metabolism// J. Lipid. Res.-2001.-V.42.-P.1513−1520.
- Segal B.M. Glass D.D., Shevach E.M. Cutting Edge: IL-10-producing CD4+ T cells mediate tumor rejection// J. Immunol.- 2002.-V.168(l).-P.l-4.
- Seglen, P. Preparation of isolated rat liver cells// Meth. Cell Biol. -1976. -Vol.13-P.29 -83.
- Senault C., Mahlberg F.H., Renaud G., Girard-Globa A., Chacko G.K. Effect of apoprotein cross-linking on the metabolism of human HDL3 in rat// Biochim.Biophys.Acta.- 1990.- V.1046.- P.81−88.
- Smit J.J., Schinkel A.H., Mol C.A., Majoor D., Mooi W.J., Jongsma A.P., Lincke C.R., Borst P. Tissue distribution of the human MDR3 P-glycoprotein// Lab. Invest.-1994,-V.71.-P.638−649.
- Somers S.D., Whisnant C.C., Adams D.O. Quantification of the strength of cell-cell adhesion: the capture of tumor cells by activated murine macrophages proceeds through two distinct stages// J. Immunol.-1986.-V. 136(4).-P. 1490−1496.
- Swaney J.B., Braithwaite F., Eder H.A. Characterization of the apolipoproteins of rat plasma lipoproteins// Biochemistry.- 1977.- V.16.-P.271−278.
- Swift L.L., Farkas M.H., Major A.S., Valyi-Nagy K., Linton M.F., Fazio S. A recycling pathway for resecretion of internalized apolipoprotein
- E in liver cells// J. Biol. Chem.- 2001.-V.276.-P.22 965−22 970.
- Taipale J., Beachy P.A. The Hedgehog and Wnt signalling pathways incancer// Nature. 2001. — Vol.411. — № 6835. — P.349 — 354.
- Tarugi P., Reggiani D., Ottaviani E., Ferrari S., Tiozzo R., Calandra S. Plasma lipoproteins, tissue cholesterol overload, and skeletal muscle apolipoprotein A-I synthesis in the developing chick// J. Lipid. Res.-1989.-V.30(l).-P.9−22.
- Tovar A.R., Torre-Villalvazo I., Ochoa M., Elias A.L., Ortiz V., Aguilar-Salinas C.A., Torres N. Soy protein reduces hepatic lipotoxicity in hyperinsulinemic obese Zucker fa/fa rats// J. Lipid Res.-2005.-V.46(9).-P.1823−1832.
- Uterman G., Steinmetz Q., Weber W. Genetic control of human apolipoprotein E polymorphism: comparison of one- and two-dimensional techniques of isoprotein analysis// Human genetics.-1982.-V.60.- P.344−351.
- Van t Hooft F.M., Dallinga-Thie G.M., Van Tol A. Leupeptinas a tool the detection of the sites of catabolism of rat highdensity lipoproteinapolipoprotein A-I and E// Biochim. Biophys. Acta.- 1985.- V.834.- N.I.-P.75−84.
- Van’t Hooft F.M., Van Tol A. The sites of degradation of rat high-density lipoprotein apolipoprotein E specifically labeled with 0−4-diazo-3 [ 125-I.iodobenzoil sucrose// Biochem.J.- 1985.- V.226.- P.715−721.
- Van Tol A., Dallinga-Thie G.M., Van Gent T., Van’t Hooft F. Specific saturable binding of rat high-density lipoproteins to rat kidney membranes// Biochim.Biophys.Acta, — 1986.- V.876.- P.340−351.
- Vogel T., Guo N.H., Guy R. et al Apolipoprotein E: a potent inhibitor of endothelial and tumor cell proliferatin // J. Cell. Biochem. 1994. -Vol.54.-№ 3.-P.299−305.
- Wang J., Kitagawa K., Kitado H., Kogishi K., Matsushita T., Hosokawa M., Higuchi K. Regulation of the metabolism of plasma lipoproteins by apolipoprotein A-II// Biochim. Biophys. Acta.-1997.-V. 1345(3).-P.248−258.
- Wang N., Chen W., Linsel-Nitschke P., Martinez L.O., Agerholm-Larsen B., Silver D.L., Tall A.R. A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I// J. Clin. Invest.-2003 .-V. 111 .-P.99−107.
- Wech P.K., Milne R.W., Milthorp P., Marcel Y. Apolipoprotein A -I from normal human plasma: definition of three distinct antigenic determinants //Biochim.Biophys.Acta.- 1985.-V.835.-N.2.- P.390−401.
- Weisgraber K.H., Innerarity T.L., Rail S.C., Mahley R.W. Receptor interactions controlling lipoprotein metabolism// Can. J.Biochem. Cell Biol.- 1985.- V.63.- P.898−905.
- Wernette-Hammmond M.E., Lawer S.J., Corsini A., Walker D., Taylor J.M., Rail S.C. Glycosilation of human apolipoprotein E. The carbohydrate attachment site is threonine 194// J. Biol. Chem.- 1987.- V.264.- P.9094−9101.
- Williams D., Dawson P., Newman T., Rudel R. Synthesis of apolipoprotein E by peripheral tissues// Ann.N.-Y.Acad.Sci.-1985. V.454.-P.222−229.
- Yamamoto T., Takahpshi S., Moriwaki Y., Hada T., Higashino K. A newly discovered apolipoprotein B-containing high-density lipoprotein produced bu human hepatoma cells// Biochim. Biophys. Acta.- 1987.-V.922,-P.177−183.
- Zannis V.I., Just P., Breslow J.L. Human apolipoprotein E isoprotein subclasses are genetically determined// Am.J.Hum.Genet.-1981 .-V.33.-P. 11 -24.
- Zerbinatti C.V., Mayer L.P., Audet R.G., Dyer C.A. Apolipoprotein E is a putative autocrine regulator of the rat ovarian theca cell compartment// Biol. Reprod. 200l.-V.64(4).-P. 1080−1089
- Zhao Y., Mazzone T. Transport and processing of endogenously synthesized ApoE on the macrophage cell surface// J. Biol. Chem.- 2000,-V.275.-P.4759−4765.
- Zheng H, Kiss RS, Franklin V, Wang MD, Haidar B, Marcel YL. ApoA-I lipidation in primary mouse hepatocytes. Separate controls for phospholipid and cholesterol transfers// J. Biol. Chem.-2005.-V.280(22).-P.21 612−21 621.
- Zuckerman S.H., Oneal L. Endotoxin and G-M-CSF-mediated down-regulation of macrophage apo E secretion is inhibited by a TNF-specific monoclonal antibody//J.Leukocyte Biology.-1994.-V.55.-P.743−748.